SEC Company Response from DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — Sep 30, 2015
DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: Sept. 30, 2015 · CIK: 0001533998 · Accession: 0001144204-15-057349
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-207066
Letter
LabStyle Innovations Corp.
9 Halamish Street
Caesarea Industrial Park
3088900, Israel
September 30, 2015
Via EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, D.C. 20549
Attn: Amanda Ravitz, Assistant Director
Re: LabStyle Innovations Corp.
Registration Statement on Form S-1
Filed September 21, 2015
File No. 333-207066
Ladies and Gentlemen:
LabStyle Innovations Corp. (the “Company”) hereby requests acceleration of the effectiveness of the above-referenced registration statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on October 2, 2015, at 4:00 p.m., Eastern Daylight Time, or as soon thereafter as is practicable.
The Company acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the above-referenced registration statement effective, it does not foreclose the Commission from taking any action with respect to the above-referenced registration statement;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the above-referenced registration statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the above-referenced registration statement; and
· The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Securities and Exchange Commission
September 30, 2015
Page 2
The Company understands that the Commission will consider this request for acceleration of the effective date of this above-referenced registration statement as a confirmation of the fact that the Company is aware of its respective responsibilities under the Securities Act and the Securities Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the above referenced registration statement.
Sincerely,
LabStyle Innovations Corp.
Show Raw Text
CORRESP
1
filename1.htm
LabStyle Innovations Corp.
9 Halamish Street
Caesarea Industrial Park
3088900, Israel
September 30, 2015
Via EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, D.C. 20549
Attn: Amanda Ravitz, Assistant Director
Re: LabStyle Innovations Corp.
Registration Statement on
Form S-1
Filed September 21, 2015
File No. 333-207066
Ladies and Gentlemen:
LabStyle Innovations Corp. (the “Company”)
hereby requests acceleration of the effectiveness of the above-referenced registration statement pursuant to Rule 461 under the
Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on October 2, 2015,
at 4:00 p.m., Eastern Daylight Time, or as soon thereafter as is practicable.
The Company acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the above-referenced registration statement
effective, it does not foreclose the Commission from taking any action with respect to the above-referenced registration statement;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the above-referenced registration
statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure
in the above-referenced registration statement; and
· The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by
the Commission or any person under the federal securities laws of the United States.
Securities and Exchange Commission
September 30, 2015
Page 2
The Company understands that
the Commission will consider this request for acceleration of the effective date of this above-referenced registration statement
as a confirmation of the fact that the Company is aware of its respective responsibilities under the Securities Act and the Securities
Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the above referenced
registration statement.
Sincerely,
LabStyle Innovations Corp.
By: /s/ Erez Raphael
Name: Erez Raphael
Title: Chief Executive Officer
cc: Tim Buchmiller
Oded Har-Even
Robert V. Condon III